Disclosures for "A Rare Case of Multiple Brain Metastases from Urothelial Cancer: A Case Report"
-
Dr. Shah has nothing to disclose.
-
Mr. Toib has nothing to disclose.
-
Dr. Verma has nothing to disclose.
-
Dr. Vartanov has nothing to disclose.
-
Dr. Zibelman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Zibelman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Exelixis. Dr. Zibelman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Replimmune. The institution of Dr. Zibelman has received research support from Exelixis. The institution of Dr. Zibelman has received research support from Bristol Myers Squibb.